The company is working through a backlog after the cyberattack hampered manufacturing, order processing and shipping.
Boston Scientific has begun to restore shipping of products roughly one week after it was hit by a cyberattack that disrupted operations throughout the company.
The medical device maker has begun restoring shipping for the majority of products at its major distribution centers globally, and it is working to restore full shipping capabilities for other products and other sites as it works up to full capacity. Boston Scientificprovided the update in a statement postedto its website on Thursday.
“As capabilities are validated and brought back online, we are progressively moving customer orders through the fulfillment process,” the company said. “It will take time to work through the existing backlog of orders.”
While shipping is still being restored, customers are able to submit orders electronically.
The company declined to comment on MedTech Dive’s request for information on whether its manufacturing capabilities are still being affected, and said updates could be found on its website.
Boston Scientific is still investigating the attack and is working with CrowdStrike and other third-party experts. In its Thursday update, Boston Scientific said that it has “growing confidence that the unauthorized access was limited to select internal-facing IT infrastructure.”
The Boston Scientific cyberattackbrought down the company’s abilityto manufacture products, as well as its ability to process and ship customers’ orders.
The incident is thelatest in a string of cyberattacksthat have plagued the medical device industry for the past six months. Some of the top companies in the space have been hit by a cyberattack, including Stryker, Medtronic, Abbott and Intuitive.
While most attacks have not disrupted operations, Stryker and Boston Scientific have experienced a significant impact. Stryker suffered an attack in March thatshut down ordering, shipping and manufacturingfor the company. The effects lasted for weeks, and while the company did not provide a specific figure for how much the attack impacted its first-quarter earnings, CEO Kevin Lobosaid that it “meaningfully” affectedStryker’s growth.
When Boston Scientific first disclosed the cyberattack last week in a securities filing, it said that it had not yet determined whether the incident would have a material impact.
The attack comes amid recent struggles for the company — Boston Scientific hascut its sales and earnings per share forecasttwice this year as key businesses faced challenges.
